---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 7:08 PM
Subject: Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium.
To: mesothelioma77@gmail.com
[1]Toxicol Appl Pharmacol. 2007 Dec 27;
Liu Z, Yu X, Shaikh ZA
Cadmium (Cd), an endocrine disruptor, can induce a variety of signaling events including the activation of ERK1/2 and AKT. In this study, the involvement of estrogen receptors (ER) in these events was evaluated in three human breast caner cell lines, MCF-7, MDA-MB-231, and SK-BR-3. The Cd-induced signal activation patterns in the three cell lines mimicked those exhibited in response to 17beta-estradiol. Specifically, treatment of MCF-7 cells, that express ERalpha, ERbeta and GPR30, to 0.5-10 muM Cd for only 2.5 min resulted in transient phosphorylation of ERK1/2. Cd also triggered a gradual increase and sustained activation of AKT during the 60 min treatment period. In SK-BR-3 cells, that express only GPR30, Cd also caused a transient activation of ERK1/2, but not of AKT. In contrast, in MDA-MB-231 cells, that express only ERbeta, Cd was unable to cause rapid activation of either ERK1/2 or AKT. A transient phosphorylation of ERalpha was also observed within 2.5 min of Cd exposure in the MCF-7 cells. While the estrogen receptor antagonist, ICI 182,780, did not prevent the effect of Cd on these signals, specific siRNA against hERalpha significantly reduced Cd-induced activation of ERK1/2 and completely blocked the activation of AKT. It is concluded that Cd, like estradiol, can cause rapid activation of ERK1/2 and AKT and that these signaling events are mediated by possible interaction with membrane ERalpha and GPR30, but not ERbeta.
___
Source: http://www.hubmed.org/display.cgi?uids=18275979
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 7:08 PM
Subject: Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium.
To: mesothelioma77@gmail.com
[1]Toxicol Appl Pharmacol. 2007 Dec 27;
Liu Z, Yu X, Shaikh ZA
Cadmium (Cd), an endocrine disruptor, can induce a variety of signaling events including the activation of ERK1/2 and AKT. In this study, the involvement of estrogen receptors (ER) in these events was evaluated in three human breast caner cell lines, MCF-7, MDA-MB-231, and SK-BR-3. The Cd-induced signal activation patterns in the three cell lines mimicked those exhibited in response to 17beta-estradiol. Specifically, treatment of MCF-7 cells, that express ERalpha, ERbeta and GPR30, to 0.5-10 muM Cd for only 2.5 min resulted in transient phosphorylation of ERK1/2. Cd also triggered a gradual increase and sustained activation of AKT during the 60 min treatment period. In SK-BR-3 cells, that express only GPR30, Cd also caused a transient activation of ERK1/2, but not of AKT. In contrast, in MDA-MB-231 cells, that express only ERbeta, Cd was unable to cause rapid activation of either ERK1/2 or AKT. A transient phosphorylation of ERalpha was also observed within 2.5 min of Cd exposure in the MCF-7 cells. While the estrogen receptor antagonist, ICI 182,780, did not prevent the effect of Cd on these signals, specific siRNA against hERalpha significantly reduced Cd-induced activation of ERK1/2 and completely blocked the activation of AKT. It is concluded that Cd, like estradiol, can cause rapid activation of ERK1/2 and AKT and that these signaling events are mediated by possible interaction with membrane ERalpha and GPR30, but not ERbeta.
___
Source: http://www.hubmed.org/display.cgi?uids=18275979
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc